Effect of electroacupuncture versus cognitive behavioral therapy for perimenopausal insomnia: a non-inferiority, randomized controlled trial
Abstract
BACKGROUND AND PURPOSE
Perimenopausal insomnia (PMI) significantly compromises the quality of life and daily functioning. Electroacupuncture (EA) is an effective non-pharmacological therapy for insomnia, but its efficacy compared to cognitive behavioral therapy for insomnia (CBT-I) is not well-established. This trial aimed to test the non-inferiority of EA compared with CBT-I for PMI.
MATERIALS AND METHODS
In this two-arm, non-inferiority randomized controlled trial, 160 women were randomly assigned to EA or CBT-I groups (n = 80 each). CBT-I was used as an active comparator to establish whether EA preserves clinical efficacy within a pre-specified margin. The primary outcome was a mean change in the Insomnia Severity Index (ISI) score from baseline to week 8. A non-inferiority margin of -4 points on the ISI was predefined.
RESULTS
At week 20, 92% (147/160) of the study participants completed follow-up, with retention rates of 95% (76/80) in the EA group and 89% (71/80) in the CBT-I group. EA demonstrated non-inferiority to CBT-I in the reduction of ISI score from baseline. The mean decrease in ISI was 6.80 (95% CI [confidence interval], 5.84 to 7.77) for EA and 9.16 (95% CI, 8.14 to 10.17) for CBT-I. The between-group difference of -2.36 (95% CI, -3.77 to -0.94) was within the non-inferiority margin. Serious adverse events were not reported.
CONCLUSION
EA effectively improves sleep quality in women with PMI and is non-inferior to CBT-I. Therefore, EA is a viable treatment…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 160 participants or records.
Read the paper
Related studies
- Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- A meta‐analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale
- Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
- Exercise interventions in Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials
- Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
- Glucocorticoid Resistance: Is It a Requisite for Increased Cytokine Production in Depression? A Systematic Review and Meta-Analysis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.